996 Combination therapy of peginterferon alfa-2A (40KD) (PEGASYS(R)) and ribavirin (COPEGUS(R)) significantly enhance sustained virological and biochemical response rate in chronic hepatitis C genotype 4 patients in Saudi Arabia

✍ Scribed by SHOBOKSHI, O; SEREBOUR, F; SKAKNI, L; ALJASSER, N; TANTAWI, A; SABAH, A; DINISH, T; ALQUAIZ, M; QAHTANI, K; SANDOKJI, A

• Book ID: 123214221
• Publisher: John Wiley and Sons
• Year: 2003
• Tongue: English
• Weight: 145 KB
• Volume: 38
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1016/S0270-9139(03)81034-0